Pay in 4 interest-free payments of $5.84 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
In South Korea, the related polynucleotide preparation Rejuran has been used as an intradermal regenerative injection for skin rejuvenation since the mid-2010s
Studies show GHK-Cu influences gene expression related to collagen synthesis and extracellular matrix remodelling
BPC-157 , also known as Body Protection Compound 157 , has shown healing and regenerative outcomes, making it a promising therapeutic agent
Key Research Findings GHK-Cu has been shown to increase collagen synthesis in fibroblast cultures by stimulating TGF- signaling pathways and upregulating collagen I/III gene expression
This combination therapy addresses multiple pathways, making it a robust solution for patients with type 2 diabetes and obesity
Phase 2 dose-finding trial (Lancet 2021) tested cagrilintide 0.3 mg through 4.5 mg/week against placebo and against liraglutide 3.0 mg
US$ 23.71
US$ 24.45
US$ 25.28
US$ 27.41
US$ 21.29
US$ 20.82
US$ 21.51
US$ 28.03
US$ 25.82
US$ 21.32
US$ 29.43
US$ 20.97
US$ 21.17
US$ 27.54
US$ 28.94
